Weekly injection for prediabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a once-weekly injection called mazdutide to see if it can help people with prediabetes improve their blood sugar and manage weight. The study compares the drug to a placebo (an injection with no active medicine).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have prediabetes (higher than normal blood sugar but not diabetes).
- Your body mass index (BMI) must be 22 or higher.
- You should not have taken diabetes medication (like metformin or insulin) for more than 7 days in the last 3 months.
- You cannot have used weight-loss injections like semaglutide or tirzepatide in the past 6 months.
- You must not have had weight-loss surgery in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication called chiglitazar sodium, combined with a lifestyle program, can help reverse prediabetes (when blood sugar is high but not yet diabetes). It could help you lower your blood sugar and reduce your risk of developing type 2 diabetes.
This study tests a once-weekly injection (HDM1005) to see if it improves blood sugar control in people with type 2 diabetes who are already taking metformin alone or with an SGLT2 inhibitor. It may help lower your A1C levels and manage your weight.
This trial tests a new medicine called mazdutide to see if it can help people with type 2 diabetes achieve remission (return to normal blood sugar levels without needing medicine). It's a placebo-controlled study, meaning some participants will get the real drug and others will get a fake one, to compare results. You must be within 5 years of diagnosis and have a BMI over 24.
This trial tests whether combining lifestyle changes (diet and exercise) with a medication called mazdutide can help adults with obesity lose weight and keep it off. Mazdutide is an injectable medication that may help reduce appetite and support weight management over 2 years.
This study tests a weekly injection called tirzepatide to see if it helps people with type 1 diabetes who are overweight or obese. The goal is to improve blood sugar control and help with weight loss.
This study tests an investigational injectable medication (HRS-4729) to see if it can improve blood sugar control in people with type 2 diabetes. It is for patients who are not on many diabetes medications yet, and the trial monitors safety and effectiveness over time.
Hear when a new Prediabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.